Tagged with LG

Algeria Moncef Meklati, Merck’s general manager for North West Africa, discusses the company’s ambitions in the region, the key to successful joint ventures and evolving attitudes to chronic diseases in Algeria.   From the first day I started working for Merck, I’ve been impressed by the strong commitment of my team…

Bristol-Meyers Squibb Last week, Bristol-Myers Squibb (BMS) announced that they have entered into a definitive merger agreement under which Bristol-Myers Squibb will acquire Celgene in a cash and stock transaction with an equity value of approximately $74 billion. Under the terms of the agreement, Celgene shareholders will receive 1.0 Bristol-Myers Squibb share…

Algeria Yahia Aktouf outlines the relationship between Aktouf Medical and Philips Healthcare in Algeria, the evolution of the Algerian medtech market and the potential to bring innovative products to North Africa.   The evolution [of the Algerian medtech sector] between 1997 and now has been very significant in terms of development…

Algeria With stiffening up of local content requirements well underway, many multinational drug developers seeking to introduce their therapies to the Algerian marketplace have been scrambling to team up with the handful of indigenous CMOs that possess the requisite quality standards and reputations to handle their brands. Here is a selection…

Algeria

Korea Jongmoon Kim, CEO of ToolGen discusses the potential for their CRISPR technology to revolutionize not only therapy for genetic illnesses, but also agriculture. Kim explains his move from information technology to biotechnology and the importance of building international partnerships across the industry.   CRISPR simplifies some of the complex tasks…

Algeria Key recent investments from Middle Eastern companies into Algerian Pharma.   Saudi company Tabuk Pharmaceuticals invests USD 20 million into a plant in Blida (2014) “We arrived in Algeria in 1997 with imports only. Then Tabuk partnered with the Central Pharmacy of Hospitals (PCH) in 2004. We had a renewed…

Algeria A sudden imposition of import restrictions on pharmaceuticals in 2017 has pushed several multinational companies to establish local production facilities in Algeria. However, the localization process can be fraught both for companies that establish direct manufacturing footprints via joint ventures and those that employ the services of local contract manufacturers.…

Algeria Doria Oughlis, Lilly’s GM for North West Africa, outlines the company’s historic presence in Algeria, current priorities and Lilly’s overarching contribution to the health of the region.   Could you please start by describing Lilly’s legacy in Algeria to date? Lilly’s presence in Algeria actually long predates the setting up…

Algeria Djaouad Braham Bourkaib, Director General of Social Security at the Algerian Ministry of Labour, Employment and Social Security, outline recent regulatory reform in the North African nation and the future of Algeria’s healthcare system.   What can you tell us about the Algerian national policy of health expense reimbursement? We…

Algeria Guillaume Seillier, general director of Servier Algeria discusses recent changes in the affiliate, localization strategies, and Algeria’s importance to Servier’s regional and global operations.   We would like to reach 100 percent local production by 2020 Could you introduce the current face of Servier and the main changes and emerging…

Algeria The global drop in oil prices in 2015-2016 hit the Algerian economy – which is heavily reliant on petroleum revenues – hard. The country’s government implemented severe economic cuts across a number of sectors  (including healthcare), to redress the balance, shuttering plans to create five new hospitals. With the multinational…